SCHEMBL28211667

SCHEMBL28211667

c1ccc(Cc2nc(Cc3ccccc3)c3ccccc3n2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.60
KMT2A Q03164 4/20 0.60
MEN1 O00255 3/20 0.60
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
CYP2D6 P10635 1/20 0.51
MAPT P10636 2/20 0.49
MAPK1 P28482 1/20 0.49
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PRNP P04156 3/20 0.47
RXFP1 Q9HBX9 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
AURKA O14965 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31682474 1.00 L3MBTL1 (0.60) L3MBTL1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL28175543 0.80 KMT2A (0.62) L3MBTL1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL27313299 0.79 DCPS (0.55) KMT2ACYP1A2MAPTALDH1A1KDM4E
SCHEMBL28189562 0.79 L3MBTL1 (0.58) L3MBTL1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL21306246 0.78 CYP2C9 (0.56) L3MBTL1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL2614741 0.76 CALM1 (0.61) L3MBTL1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL28118305 0.74 GAA (0.56) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL4859938 0.74 RAD52 (0.69) KMT2AMEN1MAPTMAPK1ALDH1A1
SCHEMBL787604 0.73 KDM4E (0.57) KMT2AMEN1MAPTALDH1A1KDM4E
SCHEMBL1108399 0.73 EGFR (0.53) L3MBTL1MAPK1ALDH1A1HTTAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107922383-A Selective anticancer compound 新加坡国立大学 2018-04-17 CN disclosed